Showing results (231-240 of 297) with videos related to

Sort By:
Pageof 30
BMC Genomics|May 14, 2024
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance)Julia C F Quintanilha, Alexander B Sibley, Yingmiao Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101Antonius A Miller, Daryl J Murry, Kouros Owzar, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance)Julia C F Quintanilha, Alexander B Sibley, Yingmiao Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
A comparison of the pharmacokinetics and pharmacodynamics of docetaxel between African-American and Caucasian cancer patients: CALGB 9871Lionel D Lewis, Antonius A Miller, Gary L Rosner, et al.
Physiological Genomics|February 28, 2008
Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertensionLiliana Moreno-Vinasco, Mardi Gomberg-Maitland, Michael L Maitland, et al.
British Journal of Cancer|March 20, 2018
Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trialMichael L Maitland, Sarina Piha-Paul, Gerald Falchook, et al.
Cancer Chemotherapy and Pharmacology|June 28, 2018
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumorsAmikar Sehdev, Theodore Karrison, Yuanyuan Zha, et al.
Investigational New Drugs|April 22, 2008
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemiaWendy Stock, Samir D Undevia, Carol Bivins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2018
Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate CancerRussell Z Szmulewitz, Cody J Peer, Abiola Ibraheem, et al.
Cancer Chemotherapy and Pharmacology|August 29, 2014
Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103)Jan H Beumer, Kouros Owzar, Lionel D Lewis, et al.
Pageof 30